Table 2.
Reporting Odds Ratio (ROR) of musculoskeletal, neurological, or psychiatric adverse drug reactions (ADRs) with quinolone generations.
| Quinolone generations | Control group |
Reporting Odds Ratio of musculoskeletal ADRs
(95% Confidence Interval) |
P-value |
|---|---|---|---|
| 1 generation | 2 generation | 0.67 (0.42–1.08) | 0.097 |
| 3 generation | 2 generation | 1.42 (1.27–1.58) | <0.001 |
| 4 generation | 2 generation | 2.06 (1.53–2.78) | <0.001 |
| 1 generation | 3 generation | 0.47 (0.30–0.76) | 0.001 |
| 2 generation | 3 generation | 0.70 (0.63–0.79) | <0.001 |
| 4 generation | 3 generation | 1.45 (1.09–1.94) | 0.011 |
| Quinolone generations | Control group |
Reporting Odds Ratio of neurological ADRs
(95% Confidence Interval) |
P-value |
| 1 generation | 2 generation | 1.83 (1.35–2.50) | <0.001 |
| 3 generation | 2 generation | 1.23 (1.11–1.38) | <0.001 |
| 4 generation | 2 generation | 1.26 (0.89–1.79) | 0.1927 |
| 1 generation | 3 generation | 1.49 (1.10–2.01) | 0.009 |
| 2 generation | 3 generation | 0.81 (0.73–0.90) | <0.001 |
| 4 generation | 3 generation | 1.02 (0.72–1.45) | 0.8953 |
| Quinolone generations | Control group |
Reporting Odds Ratio of psychiatric ADRs
(95% Confidence Interval) |
P-value |
| 1 generation | 2 generation | 1.50 (0.97–2.32) | 0.065 |
| 3 generation | 2 generation | 1.81 (1.58–2.08) | <0.001 |
| 4 generation | 2 generation | 1.08 (0.66–1.78) | 0.7544 |
| 1 generation | 3 generation | 0.83 (0.54–1.27) | 0.3840 |
| 2 generation | 3 generation | 0.55 (0.44–0.63) | <0.001 |
| 4 generation | 3 generation | 0.60 (0.36–0.97) | 0.036 |